Clinical trial Recruiting at 1 site Interventional Ages 12 to 100

SER Familia: A family program to reduce acculturative stress and build resilience in Latino immigrant families.

Official title: SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families

Run by Duke University · NCT06627764 · Data updated 2026-11-12

This program tests whether a six-session, community health worker–delivered family intervention can lower acculturative stress and reduce risks for substance use, intimate partner violence, HIV, depression, and anxiety among first-generation Latino immigrant parents and their 12–17-year-old children.

More Depression trials

Quick facts

Study typeInterventional
Ages12 Years to 100 Years
SexAll
Enrollment400 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedJune 30, 2025
Main results expectedJuly 31, 2028
Study endsJanuary 31, 2029
Registry record updatedOctober 16, 2026
Trial IDNCT06627764 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are first-generation Hispanic/Latino parents or parental figures who speak English or Spanish, have a child aged 12–17, and can attend the six-session program locally in Durham, North Carolina.

Probably not a fit

Families planning to move within two years, non-Hispanic individuals, parents without a 12–17-year-old child, or those unable to attend local sessions are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

SER Familia is a six-session family-based intervention co-developed and delivered by community health workers to reduce acculturative stress, strengthen resilience, improve parent-child and family health, and connect families with community resources addressing social determinants of health. The intervention targets a syndemic cluster of substance abuse, intimate partner violence, HIV risk, depression, and anxiety among parents and youth. Investigators will measure changes in those outcomes and examine how individual, family, and community mechanisms related to acculturative stress and resilience mediate the program's effects. Participation is for Hispanic/Latino first-generation immigrant parents with a 12–17-year-old child who speak English and/or Spanish and are able to attend local sessions.

Why it matters

Potential benefit: If successful, SER Familia could reduce multiple related health risks by lowering acculturative stress, strengthening family relationships and resilience, and improving access to local supports.

How similar studies have gone: Community health worker–led and family-based interventions in Latino populations have shown promise for reducing acculturative stress and improving mental health or substance-use outcomes, but applying a single intervention to prevent a syndemic of substance abuse, IPV, HIV risk, and mental health is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eligible participants must identify as Hispanic/Latino/a/x/e,
* be a parent or parental figure with Latin descent
* have a child (Youth) aged 12-17
* speak English and/or Spanish

Exclusion Criteria:

* Families planning to move within two years will be excluded

Where it's running

  • Duke School of Nursing
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.